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I
n  the  past  half-century,  we  have  witnessed 
substantial  advances  in  the  management  of  ST-
segment  elevated  myocardial  infarction  (STEMI) 
that have led to large reductions in case-fatality. In the 
1960s,  the  advent  of  defibrillation  and  coronary  care 
units reduced in-hospital case-fatality rates by half, from 
30% to 15%.1 The “thrombolytic era” saw even greater 
reductions in mortality with the rapid administration of 
thrombolytic therapy.2 Evidence from a number of recent 
randomized  controlled  trials  has  shown  that  primary 
percutaneous coronary intervention (PCI) is superior to 
thrombolysis provided it is delivered within 90 minutes.3 
Despite these improvements, STEMI continues to be a 
serious  and  costly  condition  that  imposes  enormous 
burdens on individuals, caregivers and Canadian society. 
In 2004, myocardial infarctions accounted for 8%, or 
18 102,4 of the 226 584 deaths nationwide.
In  Canada,  40  hospitals  are  currently  equipped  to 
provide PCI. These PCI facilities are located in larger 
urban centres in nine provinces. Given the geographic 
size of Canada and he relatively few PCI facilities, timely 
access to primary PCI for STEMI is currently available 
only to people living in or close to those urban centres. 
For Canada’s 16.6 million people aged 40 years and over, 
there is one PCI facility for every 416 000 people; this is 
a fraction of what is available in the United States, where 
140 million people aged 40 and over have access to 2100 
PCI facilities.5
Geographic  information  systems  (GIS)  are  a  novel 
way of studying the effects of regionalization that can 
help guide strategies for resource allocation in Canada 
and  other  countries  with  a  large  land  mass  whose 
populations are concentrated in relatively few cities. In 
this issue of Open Medicine, Patel and colleagues report 
the estimated travel times by ground transportation to 
PCI facilities across Canada.6 They used the geographic 
centre  of  individual  census  dissemination  areas  (the 
smallest geographic unit at which the census is public-
ly distributed) as the originating point of travel. These 
distances were used to estimate the proportion of the 
Canadian  population  aged  40  and  older  with  timely 
access to PCI facilities (within 60, 90 and 120 minutes). 
The  authors  found  that  63.9%  of  Canadians  40  years 
of age and older had access to a PCI facility within 60 
minutes, 72.4% within 90 minutes and 78.8% within 120 
minutes. 
Patel and colleagues also examined the effect on these 
estimates of the hypothetical addition of a new PCI fa- s of the hypothetical addition of a new PCI fa-  of the hypothetical addition of a new PCI fa- of the hypothetical addition of a new PCI fa-
cility in medium-sized cities in the four most populated 
provinces: �elowna (�ritish Columbia), �ethbridge (�l- �elowna (�ritish Columbia), �ethbridge (�l-  (�ritish Columbia), �ethbridge (�l- , �ethbridge (�l-  (�l-
berta), St. Catharines (�ntario) and Trois �ivi�res (�ue- , St. Catharines (�ntario) and Trois �ivi�res (�ue- t. Catharines (�ntario) and Trois �ivi�res (�ue-  Catharines (�ntario) and Trois �ivi�res (�ue- (�ntario) and Trois �ivi�res (�ue- and Trois �ivi�res (�ue-  (�ue-
bec). They estimated that the proportion of the population 
with access to a PCI facility within 60 minutes would 
increase by 3.2% and 4.3% depending on the province. 
They also estimated that about 17 deaths within four to 
six weeks of an acute myocardial infarction (�MI) and 
34 recurrent nonfatal myocardial infarctions or strokes 
could  be  avoided  through  the  addition  of  these  four 
hypothetical facilities. 
GIS analyses have an important and growing role in 
health  services  and  population  health  research.  They 
provide  useful  tools  to  document  inequity  in  access 
to  services  across  communities  and  neighbourhoods. 
They can also be used to assess populations at risk for 
environmental  exposures,  to  optimize  allocation  of 
human  resources,  to  identify  effective  and  convenient 
means  of  transportation  to  facilities  and  services  for 
users,  and  to  characterize  the  health  needs  of  specific 
populations.  Investigators  are  now  moving  beyond  the 
technical implementation by using GIS to develop practical knowledge about person, place and time. For example, 
an earlier study by some of the same authors analyzed 
geographic areas and populations with timely access to 
PCI facilities by different modes of transportation in the 
province of �lberta.7 They found that, compared with air 
ambulance, ground transportation by ambulance covered 
a greater proportion of the population and, in some areas, 
greater distances within the critical 90-minute window. 
They  concluded  that,  in  �lberta,  air  ambulances  were 
not an effective means of transporting patients to a PCI 
facility.
In  the  current  study,  Patel  and  colleagues  show  an 
interesting  and  straightforward  application  of  GIS 
analysis. The road network analysis using GIS is beneficial 
in incorporating a temporal component of geographic ac-
cess. �s expected, the authors found that “The hypothet- that “The hypothet- The hypothet-
ical addition of a new PCI facility in each of the 4 most 
populated provinces would increase the proportion of the 
population with timely access.” �ased on their analyses, 
they seem to be advocating for new PCI facilities. �lthough 
the straightforward study design may seem compelling, 
we think that Patel and colleagues have oversimplified 
the issue and that numerous other factors are required to 
develop models for regionalized STEMI care. 
First,  serious  concerns  have  been  raised  about  the 
assertion that PCI is superior to thrombolysis, including 
potential  biases  and  confounding  that  threaten  the 
internal validity of the randomized trials.8,9 For example, 
although randomized clinical trials have confirmed the 
superiority of PCI over fibrinolysis,10 patients enrolled 
in  the  larger  trials  were  selected  mostly  from  high-
volume centres. Studies from the late 1980s and 1990s 
showed reduced mortality and better outcomes in PCI 
facilities  with  larger  volumes,  which  led  to  the  2001 
consensus recommendation of a minimum institutional 
requirement of 400 procedures per year.11 Since then, 
improvements  in  PCI,  including  stenting  and  better 
technology, have made the procedure considerably safer, 
such that the relation between volume and in-hospital 
mortality has weakened.12 Nevertheless, there remains 
a  relation  between  patient  volume  and  major  adverse 
cardiovascular events,13 and technological improvements 
have  yet  to  completely  offset  the  effect  of  volume  on 
PCI  outcomes.14  That  finding  is  of  direct  relevance  to 
regionalized STEMI care models in Canada. The low- models in Canada. The low-
er procedural volumes that would be likely in the four 
hypothetical PCI facilities described by Patel and col-
leagues may be prone to suboptimal patient outcomes. 
The external validity of the randomized trials must also 
be considered carefully: one trial enrolled only 17% of 
the  screened  population,15  which  begs  the  question  of 
the applicability of the results; in another trial, from the 
United States, only 4% of patients were treated within 
the critical 90-minute window.16
Second, the authors estimated that, each year, “about 
17 deaths that would have occurred within 4–6 weeks of 
an �MI and 34 recurrent nonfatal myocardial infarctions 
or strokes could be avoided through the addition of these 
4  hypothetical  facilities.”  �gain,  we  believe  that  their 
analysis is oversimplified. The development of credible 
estimates of this nature would require more robust and 
better described methodology that included estimates of 
dispersion and of the degree of confidence in the results. 
In  the  worst  case,  those  numbers  could  be  quoted 
inappropriately.
Third,  even  if  the  authors’  estimates  are  correct, 
basing the case for new PCI facilities on avoiding such 
a relatively small number of deaths within four to six 
weeks of an �MI—which amount to less than 0.01% of 
the 201 488 deaths in the 4 target provinces in 2008—
might be used as evidence against the addition of those 
facilities.
�egardless of whether primary PCI or fibrinolysis is 
chosen, the successful reperfusion of the infarct-related 
artery in the shortest amount of time is a key determinant 
of  optimal  patient  outcomes.  Contemporary  evidence 
suggests that the speed of reperfusion after infarct onset 
may  be  more  important  than  whether  mechanical  or 
pharmacological intervention is used. Furthermore, the 
evidence suggests that the impact of delay to reperfusion 
on outcome depends considerably on patient age, infarct 
location and symptom duration.17 For example, a patient 
younger  than  65  years  with  an  anterior  myocardial 
infarction and less than 2 hours of symptoms can have 
a  PCI-related  delay  of  only  40  minutes.  Conversely,  a 
patient  65  years  or  older  with  an  inferior  myocardial 
infarction  and  at  least  2  hours  of  symptoms  can  be 
subjected to a PCI-related delay of 179 minutes.17
In terms of allocating resources, would investments 
other  than  new  PCI  facilities  reduce  the  burden  of 
STEMI  to  a  greater  degree?  Policies  to  reduce  travel 
times to existing facilities may be more effective or less 
costly for achieving the same outcomes. For example, 
studies done in Calgary and �ttawa have shown that pre-
hospital assessment and direct transfer (bypassing the 
emergency department) to the appropriate facility can 
speed access to PCI.18,19 �lthough these strategies are not 
applicable to Canadians living in areas without a nearby 
PCI  facility,  organizational  strategies  such  as  those 
could be more effective in shortening the mean delay to 
PCI, be less expensive, and be more straightforward to 
implement than the addition of new PCI facilities.
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regionalized STEMI care models is the question “how 
can the highest proportion of the Canadian population 
be provided with rapid access to PCI?” That question, 
which views access to PCI in isolation, is not useful for 
decision-makers.  More  relevant  questions  are  “How 
much PCI should the health care system provide?” “How 
quickly?” and “To which patients?”20 Current guidelines 
explicitly recognize that the “emphasis on PCI should 
not  obscure  the  importance  of  fibrinloytic  therapy”21 
and  that  a  regionalized  STEMI  care  model  must 
include  all  alternative  therapies,  including  facilitated 
PCI  (administration  of  thrombolysis  before  a  planned 
immediate PCI) and thrombolysis. From an economic 
point of view, even if, on balance, PCI is considered cost-
effective  relative  to  thrombolysis  for  treating  STEMI, 
Canada’s  large  geographic  size  necessitates  a  mix  of 
services  because  thrombolysis  is  easier  to  administer 
and requires less specialized equipment. Even then, the 
incremental cost-effectiveness of PCI will vary according 
to  many  factors,  among  them  distance  to  the  facility, 
volume and organization of STEMI treatment.
More generally, tertiary care cardiology services must 
be viewed in the context of delivering all health services 
and  other  societal  goods  by  explicitly  considering 
technical efficiency (the degree to which a given set of 
inputs  is  used  to  produce  an  output)  and  allocative 
efficiency (the degree of benefit derived from a specific 
distribution of resources).22 The line of reasoning that 
seeks the most efficient ways of delivering health care is 
consistent with the ethical stance arising from a single 
public payer constrained by a fixed health care budget. 
�f  course,  other  ethical  stances  must  be  considered, 
including the rights of all Canadians to timely access to 
treatment for STEMI.23 
Health  services  researchers  must  take  the  lead  in 
developing a modern approach to health care delivery by 
identifying and testing new policies designed to equitably 
meet  the  health  needs  of  the  entire  population.  For 
example, the demographic composition of the population 
determines to a large degree which health services are 
required. Given the rapid increase in the rate of acute 
coronary syndromes after age 50 years and the increas-  and the increas-
ing size of our elderly population, there may be a need 
for increased services to treat STEMI in Canada. That 
trend may be offset by lower age-standardized rates of 
death from �MI, which declined substantially between 
1994  and  2004.4  �lthough  the  information  is  dated, 
investigators have attributed two-thirds of this decline 
to  healthier  lifestyles  and  better  primary  prevention 
and  one-third  to  reduced  case-fatality  rates  owing 
mainly to treatments.24,25 Studies designed to increase 
knowledge about the interplay between these trends are 
critical for planning services for cardiovascular health 
promotion, prevention and treatment. GIS analysis can 
play an important role in that effort by helping assess 
the population at highest risk for cardiovascular disease, 
describing the need for services and identifying effective 
means of transportation to PCI facilities.
� modern approach to examining the delivery of health 
services must go beyond studying isolated tertiary care 
services such as PCI. �lthough Patel and colleagues pro-
vide information on population coverage that would be 
required for establishing new PCI facilities, their region-
alized STEMI care model views PCI in isolation, does 
not estimate the return on investment and is predicated 
on adding hypothetical PCI facilities based on existing 
models of care delivery. In the face of increasing expecta-
tions from the public and greater fiscal constraints, real 
improvements in efficiency, sustainability, quality and 
appropriateness of health care require new methods of 
delivering services that go beyond growth of the existing 
system. Without doing so, a reasoned and cohesive plan 
for  developing  a  sustainable,  responsive,  transparent 
and equitable health care system will remain elusive.
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